Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway (Q45012986)

8 December 2017

title

Topiramate in the treatment of migraine: a kainate (glutamate) receptor antagonist within the trigeminothalamic pathway (English)

1 reference

8 December 2017

1 reference

2

Peter J Goadsby

1 reference

8 December 2017

Anna P Andreou

1

1 reference

8 December 2017

language of work or name

English

0 references

publication date

5 September 2011

1 reference

8 December 2017

1 reference

8 December 2017

volume

31

1 reference

8 December 2017

issue

13

1 reference

8 December 2017

page(s)

1343-1358

1 reference

The global burden of disease study: implications for neurology

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Cost of disorders of the brain in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Migraine--current understanding and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

The pharmacology of headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Migraine prevalence, disease burden, and the need for preventive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Fibrotic Disorders Associated with Methysergide Therapy for Headache

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Current practice and future directions in the prevention and acute management of migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Sugar sulfamates for seizure control: discovery and development of topiramate, a structurally unique antiepileptic drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Anticonvulsants in migraine prophylaxis: a Cochrane review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

New drugs in migraine treatment and prophylaxis: telcagepant and topiramate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate for migraine prevention: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate in migraine prophylaxis--results from a placebo-controlled trial with propranolol as an active control

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate in migraine prevention: results of a large controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Cessation versus continuation of 6-month migraine preventive therapy with topiramate (PROMPT): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate intervention to prevent transformation of episodic migraine: The topiramate INTREPID study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Genome-wide association study reveals three susceptibility loci for common migraine in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

A nomenclature for ligand-gated ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

21 January 2018

Neuroimaging of migraine

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

A neural mechanism for exacerbation of headache by light

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: a role in migraine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Migraine: gene mutations and functional consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

GluR5 Kainate Receptors and Topiramate: A New Site of Action for Antiepileptic Drugs?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate selectively protects against seizures induced by ATPA, a GluR5 kainate receptor agonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Use of chronic epilepsy models in antiepileptic drug discovery: the effect of topiramate on spontaneous motor seizures in rats with kainate-induced epilepsy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Effects of topiramate on kainate- and domoate-activated [14C]guanidinium ion flux through GluR6 channels in transfected BHK cells using Cytostar-T scintillating microplates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Clinical experience with topiramate dosing and serum levels in patients with epilepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate inhibits trigeminovascular neurons in the cat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate inhibits cortical spreading depression in rat and cat: impact in migraine aura

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Topiramate inhibits trigeminovascular activation: an intravital microscopy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Activation of iGluR5 kainate receptors inhibits neurogenic dural vasodilatation in an animal model of trigeminovascular activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Presynaptic low- and high-affinity kainate receptors in nociceptive spinal afferents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Significant linkage to migraine with aura on chromosome 11q24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

LY293558, a novel AMPA/GluR5 antagonist, is efficacious and well-tolerated in acute migraine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Release of glutamate and CGRP from trigeminal ganglion neurons: Role of calcium channels and 5-HT1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Clinical pharmacology of topiramate: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

Animal models of headache: from bedside to bench and back to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1177/0333102411418259

21 January 2018

Identifiers

DOI

10.1177/0333102411418259

1 reference

8 December 2017

1 reference